Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 113631574 | 11363157 | 4 | F | 201506 | 20160830 | 20150811 | 20160905 | EXP | US-ASTRAZENECA-2015SE75620 | ASTRAZENECA | 872.00 | MON | F | Y | 86.60000 | KG | 20160905 | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 113631574 | 11363157 | 1 | PS | TUDORZA PRESSAIR | ACLIDINIUM BROMIDE | 1 | Respiratory (inhalation) | 1136201,1136132,1134337,1147844 | 202450 | 400 | UG | INHALATION POWDER | BID | ||||||
| 113631574 | 11363157 | 2 | SS | TUDORZA PRESSAIR | ACLIDINIUM BROMIDE | 1 | Respiratory (inhalation) | 1136201,1136132,1134337,1147844 | 202450 | 400 | UG | INHALATION POWDER | BID | ||||||
| 113631574 | 11363157 | 3 | SS | TUDORZA PRESSAIR | ACLIDINIUM BROMIDE | 1 | Respiratory (inhalation) | 1136201,1136132,1134337,1147844 | 202450 | 400 | UG | INHALATION POWDER | BID | ||||||
| 113631574 | 11363157 | 4 | SS | OMEPRAZOLE. | OMEPRAZOLE | 1 | Oral | 0 | 20 | MG | BID | ||||||||
| 113631574 | 11363157 | 5 | SS | OMEPRAZOLE. | OMEPRAZOLE | 1 | Oral | 0 | 20 | MG | BID | ||||||||
| 113631574 | 11363157 | 6 | SS | OMEPRAZOLE. | OMEPRAZOLE | 1 | Oral | 0 | 20 | MG | QD | ||||||||
| 113631574 | 11363157 | 7 | SS | OMEPRAZOLE. | OMEPRAZOLE | 1 | Oral | 0 | 20 | MG | QD | ||||||||
| 113631574 | 11363157 | 8 | SS | DALIRESP | ROFLUMILAST | 1 | Oral | 0 | TABLET | ||||||||||
| 113631574 | 11363157 | 9 | SS | DALIRESP | ROFLUMILAST | 1 | Oral | 0 | TABLET | ||||||||||
| 113631574 | 11363157 | 10 | C | OXYGEN. | OXYGEN | 1 | Respiratory (inhalation) | INCREASED DOSE FROM 2 L TO 6 L | 0 | ||||||||||
| 113631574 | 11363157 | 11 | C | BROVANA | ARFORMOTEROL TARTRATE | 1 | Respiratory (inhalation) | 0 | 15 | UG | Q12H | ||||||||
| 113631574 | 11363157 | 12 | C | PROAIR HFA | ALBUTEROL SULFATE | 1 | Respiratory (inhalation) | 180.0UG AS REQUIRED | 0 | 180 | UG | ||||||||
| 113631574 | 11363157 | 13 | C | POTASSIUM | POTASSIUM | 1 | Oral | 0 | 10 | MEQ | QD | ||||||||
| 113631574 | 11363157 | 14 | C | POTASSIUM | POTASSIUM | 1 | Oral | EXTRA 10 MEQ ON MONDAY WEDNESDAY AND FRIDAY WHEN SHE TAKES LASIX | 0 | ||||||||||
| 113631574 | 11363157 | 15 | C | LASIX | FUROSEMIDE | 1 | Oral | 0 | 20 | MG | TIW | ||||||||
| 113631574 | 11363157 | 16 | C | PREDNISONE. | PREDNISONE | 1 | Oral | 0 | 20 | MG | QOD | ||||||||
| 113631574 | 11363157 | 17 | C | ZOCOR | SIMVASTATIN | 1 | Oral | 0 | 20 | MG | QD | ||||||||
| 113631574 | 11363157 | 18 | C | LEXAPRO | ESCITALOPRAM OXALATE | 1 | Oral | 0 | 30 | MG | QD | ||||||||
| 113631574 | 11363157 | 19 | C | IRON | IRON | 1 | Oral | 239 MG OR 27 MG, DAILY | 0 | ||||||||||
| 113631574 | 11363157 | 20 | C | CALCIUM WITH VITAMIN D | CALCIUMVITAMIN D | 1 | Oral | CALCIUM 600 MG WITH 800 IU OF VITAMIN D DAILY | 0 | ||||||||||
| 113631574 | 11363157 | 21 | C | VITAMIN D | CHOLECALCIFEROL | 1 | Oral | 0 | /wk | ||||||||||
| 113631574 | 11363157 | 22 | C | ATIVAN | LORAZEPAM | 1 | Oral | 0.25MG AS REQUIRED | 0 | .25 | MG | ||||||||
| 113631574 | 11363157 | 23 | C | GAS RELIEF | DIMETHICONE | 1 | Oral | 80.0MG AS REQUIRED | 0 | 80 | MG | ||||||||
| 113631574 | 11363157 | 24 | C | MUCINEX | GUAIFENESIN | 1 | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 113631574 | 11363157 | 1 | Chronic obstructive pulmonary disease |
| 113631574 | 11363157 | 2 | Asthma |
| 113631574 | 11363157 | 3 | Bronchitis |
| 113631574 | 11363157 | 4 | Dysphagia |
| 113631574 | 11363157 | 5 | Gastric disorder |
| 113631574 | 11363157 | 6 | Dysphagia |
| 113631574 | 11363157 | 7 | Gastric disorder |
| 113631574 | 11363157 | 8 | Chronic obstructive pulmonary disease |
| 113631574 | 11363157 | 9 | Chronic obstructive pulmonary disease |
| 113631574 | 11363157 | 10 | Dyspnoea |
| 113631574 | 11363157 | 11 | Chronic obstructive pulmonary disease |
| 113631574 | 11363157 | 12 | Dyspnoea |
| 113631574 | 11363157 | 13 | Dyspnoea |
| 113631574 | 11363157 | 14 | Dyspnoea |
| 113631574 | 11363157 | 15 | Fluid retention |
| 113631574 | 11363157 | 16 | Dyspnoea |
| 113631574 | 11363157 | 17 | Blood cholesterol abnormal |
| 113631574 | 11363157 | 18 | Depression |
| 113631574 | 11363157 | 19 | Anaemia |
| 113631574 | 11363157 | 20 | Bone disorder |
| 113631574 | 11363157 | 22 | Dyspnoea |
| 113631574 | 11363157 | 23 | Flatulence |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 113631574 | 11363157 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 113631574 | 11363157 | Asthma | |
| 113631574 | 11363157 | Confusional state | |
| 113631574 | 11363157 | Device damage | |
| 113631574 | 11363157 | Device leakage | |
| 113631574 | 11363157 | Dry mouth | |
| 113631574 | 11363157 | Dyspnoea | |
| 113631574 | 11363157 | Intentional product misuse | |
| 113631574 | 11363157 | Lung disorder | |
| 113631574 | 11363157 | Oxygen saturation decreased | |
| 113631574 | 11363157 | Product quality issue |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 113631574 | 11363157 | 1 | 2013 | 0 | ||
| 113631574 | 11363157 | 2 | 2013 | 0 | ||
| 113631574 | 11363157 | 3 | 2013 | 0 | ||
| 113631574 | 11363157 | 8 | 201511 | 201511 | 0 | |
| 113631574 | 11363157 | 9 | 20151217 | 0 |